Institutional members access full text with Ovid®

Share this article on:

The Skoog Lip Repair for Unilateral Cleft Lip Deformity: The Uppsala Experience

Falk-Delgado, Alberto, M.D., M.Sc., Ph.D.; Lång, Anna, M.D.; Hakelius, Malin, M.D., Ph.D.; Skoog, Valdemar, M.D., Ph.D.; Nowinski, Daniel, M.D., Ph.D.

Plastic and Reconstructive Surgery: May 2018 - Volume 141 - Issue 5 - p 1226–1233
doi: 10.1097/PRS.0000000000004321
Pediatric/Craniofacial: Original Articles
Discussion

Background: The Uppsala Craniofacial Center has been treating patients with unilateral cleft lip deformity using the lip repair technique described by Tord Skoog. The aim of this study was to determine complications after lip surgery and the incidence and indications for lip revisions in all patients born with unilateral cleft lip from 1960 to 2004.

Methods: All patients who were born from 1960 to 2004 with unilateral cleft lip, cleft lip and alveolus, or cleft lip and palate and underwent lip repair were studied retrospectively. The timing, indication, complications of the primary procedure, and type of secondary surgery were recorded. Kruskal-Wallis and Fisher’s exact tests were used, with Bonferroni correction.

Results: The study included 443 patients. The total rate of early surgical complications was 6 percent (n = 26). Secondary surgery for short upper lip was performed in 3.8 percent (n = 17), 8.4 percent (n = 37) underwent reduction of excess vermillion, 8.6 percent (n = 38) underwent scar revision, 11 percent (n = 51) underwent revision for incongruent vermillion-cutaneous border, and 10 percent (n = 45) underwent revision for other indications. Altogether, 45 percent had no secondary revisions.

Conclusion: In conclusion, the Skoog lip repair is associated with a low total revision rate, and a short-lip deformity is rare.

CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Uppsala, Sweden

From the Department of Surgical Sciences, Plastic Surgery, Uppsala University.

Received for publication May 19, 2017; accepted December 1, 2017.

Disclosure: Dr. Falk-Delgado has a research residency funded by Uppsala University Hospital. The authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the text; simply type the URL address into any Web browser to access this content. Clickable links to the material are provided in the HTML text of this article on the Journal’s website (www.PRSJournal.com).

Alberto Falk-Delgado, M.D., M.Sc., Ph.D., Department of Surgical Sciences, Plastic Surgery, Uppsala University, Ing. 78/79, Akademiska Sjukhuset, Uppsala 75185, Sweden, alberto.falk-delgado@surgsci.uu.se

©2018American Society of Plastic Surgeons